Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 07;:104791
Authors: Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N, C-20-15 DisCoVeRy French Steering Committee
Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
PMID: 32275914 [PubMed - as supplied by publisher]